Retinopathy of Prematurity Clinical Trials

Find Retinopathy of Prematurity Clinical Trials Near You

Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care 3 (BabySTEPS3)

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Retinopathy of prematurity (ROP) is a disorder of development of the retina and its vasculature that can impact vision in vulnerable preterm neonates for a lifetime. A major barrier to improving ROP outcomes is the lack of easy access and low stress means to obtain objective measures of ROP disease severity across the retina in these infants. The long-term goal of this program is to provide information which will improve preterm infant health and vision via objective bedside imaging and analysis that characterizes retina-wide ROP level of disease, its response to treatment and development, and to rapidly translate this for better early intervention and improved future vision care.

Eligibility
Participation Requirements
Sex: All
Maximum Age: 9 months
Healthy Volunteers: f
View:

• Health care provider, knowledgeable of protocol, agrees that study personnel could contact the Parent/Legal guardian

• Parent/Legal Guardian is able and willing to consent to study participation for the infant

• Infant meets the American Association of Pediatrics eligibility of ROP screening, and is age \< 35 weeks postmenstrual age at first visit

• Infants transferred to nursery for ROP treatment (some participants)

Locations
United States
North Carolina
Duke University Eye Center
RECRUITING
Durham
Pennsylvania
University of Pennsylvania, Center for Preventive Ophthalmology and Biostatistics
ACTIVE_NOT_RECRUITING
Philadelphia
Contact Information
Primary
Xi Chen, MD
xi2.chen@duke.edu
919-684-8434
Backup
Michelle N McCall, MCAPM, BA
michelle.mccall@duke.edu
919-684-0544
Time Frame
Start Date: 2026-12-01
Estimated Completion Date: 2031-12-31
Participants
Target number of participants: 175
Treatments
Experimental: Test bedside UWF-OCT versus bionocular indirect ophthalmoscopic exam to identify RW-ROP and TR-ROP
175 infants at risk for retinopathy of prematurity will be enrolled and have beside ultra-widefield OCT retinal imaging and standard-of-care binocular indirect ophthalmoscopic (BIO) exam.
Experimental: Test bedside UWF-OCT versus fundus photos to identify RW-ROP and TR-ROP
455 infants at risk for retinopathy of prematurity: 175 infants will be enrolled and have beside ultra-widefield OCT retinal imaging, fundus imaging, and binocular indirect ophthalmoscopic exam. Data from newly enrolled infants will be combined with 280 infants who had similar imaging in BabySTEPS1, BabySTEPS2, and the Duke Investigational Pediatric OCT study to perform artificial intelligence (AI) based RW-ROP and TR-ROP severity assessment and to add OCT risk measures to AI-based prediction of RW-ROP and TR-ROP.
Experimental: Test UWF-OCT versus binocular indirect ophthalmoscopic exam to characterize ROP regression
45 infants treated for ROP: Compare OCT measures to clinical findings of ROP regression and identify early signs of ROP reactivation.
Sponsors
Leads: Duke University
Collaborators: National Eye Institute (NEI), University of Pennsylvania

This content was sourced from clinicaltrials.gov